Physician profile
Devi Morrison Walters
NPI 1659891083
$361.17
in general payments reported to CMS, 2019-2025
11 companies · $87.21 in 2025
The $87.21 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.71 · 2023: $48.74 · 2024: $210 · 2025: $87.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $68.25 | 2025 | Azstarys |
| Alk-Abello, INC | $51.58 | 2023-2024 | Ragwitek, Odactra, Grastek |
| Ironshore Pharmaceuticals INC. | $47.81 | 2019-2024 | |
| Cranial Technologies, INC | $38.83 | 2024 | Doc Band |
| Pfizer INC. | $35.02 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $27.99 | 2024 | |
| Biomarin Pharmaceutical INC. | $22.92 | 2024 | Voxzogo 1.2mg |
| Sobi, INC | $20.72 | 2024 | |
| Glaxosmithkline, LLC. | $16.97 | 2023 | Bexsero |
| Astrazeneca Pharmaceuticals Lp | $15.64 | 2024 | Flumist Quadrivalent |
| Neos Therapeutics, Lp | $15.44 | 2024 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devi Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.